Daniel Stetson
0000-0002-3961-2739
Publication & Citation Trends
Publications
0 total
Computational design of constitutively active cGAS
Cited by 13
Semantic Scholar
Early cellular mechanism of type I interferon-driven susceptibility to tuberculosis OA
Cited by 0
Semantic Scholar
ABCC1 transporter exports the immunostimulatory cyclic dinucleotide cGAMP. OA
Cited by 97
Semantic Scholar
ADAR1 mutation causes ZBP1-dependent immunopathology OA
Cited by 165
Semantic Scholar
Cellular sources and targets of type I interferons that drive susceptibility to tuberculosis
Cited by 2
Semantic Scholar
Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology OA
Cited by 211
Semantic Scholar
Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions OA
Cited by 25
Semantic Scholar
A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies OA
Cited by 5
Semantic Scholar
ABCC1/MRP1 exports cGAMP and modulates cGAS-dependent immunity
Cited by 1
Semantic Scholar
The type I interferonopathies: 10 years on OA
Cited by 343
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(36)
Lung Cancer Treatments and Mutations
(16)
Chronic Lymphocytic Leukemia Research
(13)
Lymphoma Diagnosis and Treatment
(12)
Molecular Biology Techniques and Applications
(10)
Affiliations
AstraZeneca (United Kingdom)
Boston University
Johns Hopkins University
St Petersburg University
University of Florida